Liminatus Pharma Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Liminatus Pharma Inc.
Former names: Iris Parent Holding Corp.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation: Delaware
Headquarters city: Cerritos
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: December
Ticker symbol: LIMN
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001971387

Board of directors

Follow this board

Chris Kim · Director · Chief Executive Officer
Since 2025
Eun Sook Lee · Director
Since 2025
Ii Philip Wayne Lemons · Director
Since 2025
Ji Yeon Baek · Director
Since 2025
Nicholas Fernandez · Director
Since 2025
Richard JaiHwan Baek · Director
Since 2025

Chief executives

Chris Kim · Chief Executive Officer

Since April 2025

Director election results

Annual meeting of August 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Nicholas Fernandez

99.0%
Ji Yeon Baek

99.0%

Board connections

1 of this board's directors also sit on 2 other boards.

Shared director Other board Same sector

JATT II Acquisition Corp
via Nicholas Fernandez
JATT III Acquisition Corp
via Nicholas Fernandez

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Jul 2, 2026	Chris Kim Director, Officer (Chief Executive Officer), 10% owner	Other	+3,448,926	—	—
Jun 24, 2026	Chris Kim Director, Officer (Chief Executive Officer), 10% owner	Other	−4,373,603	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Liminatus Pharma Inc.

Who is the CEO of Liminatus Pharma Inc.?

Chris Kim has been Liminatus Pharma Inc.'s Chief Executive Officer since April 2025.

How many directors are on Liminatus Pharma Inc.'s board?

Liminatus Pharma Inc.'s board has 6 directors: Chris Kim, Eun Sook Lee, Ii Philip Wayne Lemons, Ji Yeon Baek, Nicholas Fernandez and Richard JaiHwan Baek.

How is Liminatus Pharma Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="liminatus-pharma-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.